| Identification | Back Directory | [Name]
AVENANTHRAMIDEC | [CAS]
116764-15-9 | [Synonyms]
AVENANTHRAMIDEC
Avenanthramide Bc
N-[3′,4′-Dihydroxy-(E)-cinnamoyl]-5-hydroxyanthranilic acid
2-{[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]amino}-5-hydroxybenzoic acid
Benzoic acid, 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]-5-hydroxy- | [Molecular Formula]
C16H13NO6 | [MDL Number]
MFCD23380831 | [MOL File]
116764-15-9.mol | [Molecular Weight]
315.28 |
| Chemical Properties | Back Directory | [Melting point ]
248-250°C (dec.) | [Boiling point ]
702.3±60.0 °C(Predicted) | [density ]
1.582±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
Methanol (Slightly, Heated) | [form ]
neat | [pka]
3.37±0.36(Predicted) | [color ]
Pale Yellow to Light Yellow | [BRN ]
3624543 |
| Hazard Information | Back Directory | [Uses]
Avenanthramide C is an antioxidant and an anti-inflammatory agent. Avenanthramide reduces and attenuates proliferation of colonic cancer cells. Avenanthramide C inhibits chymotrypsin activity and moderately trypsin activity. | [Definition]
ChEBI: 2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid is an alkaloid and a member of benzamides. |
|
| Company Name: |
Puripharm Co., Ltd.
|
| Tel: |
0572-2745768-1 13167223168 |
| Website: |
http://www.puriactives.com/ |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|